What is Synchrony Labs?
Founded by cardiology pioneers at Duke University Medical School, Synchrony Labs operates as a premier provider of preclinical medical device testing and regulatory consulting. The company distinguishes itself through a rigorous commitment to GLP-compliant studies, bridging the gap between early-stage innovation and clinical application. By leveraging a multidisciplinary team of veterinarians, physicians, and data scientists, the firm offers a comprehensive suite of services designed to navigate the complexities of FDA approval. Their market position is defined by a four-decade legacy of excellence, ensuring that medical technologies meet the highest standards of safety and efficacy before reaching human trials.
How much funding has Synchrony Labs raised?
Synchrony Labs has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Synchrony Labs
PPP
Public-Private Partnership
What's next for Synchrony Labs?
With this late-stage capital injection, Synchrony Labs is well-positioned to expand its operational capacity and enhance its technological capabilities in preclinical research. The strategic focus will likely shift toward optimizing throughput for complex medical device trials and strengthening its regulatory consulting arm to meet the evolving demands of the global healthcare market. By investing in advanced data analytics and infrastructure, the company aims to accelerate the path to market for its clients, ultimately reducing the time and cost associated with bringing life-changing medical advancements to patients. This growth trajectory reinforces the firm's status as an essential partner in the medical innovation ecosystem.
See full Synchrony Labs company page
